Drug Shortage Report for APO-TRIAMCINOLONE AQ
Report ID | 125366 |
Drug Identification Number | 02437635 |
Brand name | APO-TRIAMCINOLONE AQ |
Common or Proper name | TRIAMCINOLONE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | TRIAMCINOLONE ACETONIDE |
Strength(s) | 55MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL NASAL |
Packaging size | 120 MS |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-09-28 |
Estimated end date | Unknown |
Actual end date | 2020-10-09 |
Shortage status | Resolved |
Updated date | 2020-10-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-09-30 | English | Compare |
v2 | 2020-09-30 | French | Compare |
v3 | 2020-10-13 | English | Compare |
v4 | 2020-10-13 | French | Compare |
Showing 1 to 4 of 4